Faeth Therapeutics, Inc. FTH
7.88 USD -0.81 (-9.32%)
Regular-session close
7.88 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
7.85 Day range 9.13
7.45 52-week range 42.14
- YTD
- -26.15%
- 1 year
- -10.45%
Held by funds
15 US ETFs and mutual funds hold FTH · largest positions
- VTI 0.00% of fund $21.03M
- VXF 0.01% of fund $6.60M
- FSMAX 0.01% of fund $2.67M
- XBI 0.02% of fund $2.41M
- FSKAX 0.00% of fund $1.15M
- SCHA 0.00% of fund $1.09M
- IWC 0.07% of fund $792.99K
- FNCMX 0.00% of fund $528.69K
- VBINX 0.00% of fund $358.31K
- VITPX 0.00% of fund $320.03K
- ITOT 0.00% of fund $315.67K
- SCHB 0.00% of fund $131.86K
- LABU 0.02% of fund $87.52K
- TDNA 0.16% of fund $17.80K
- TXS 0.01% of fund $5.92K
Ownership
- Institutions 78.8%
- Insiders 1.62%
- Public and other holders 19.5%
Held by insiders 1.62%
Held by institutions 78.84%
Float held by institutions 80.13%
Institutions 57
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Montanova Capital LLC | 7.82% | 2,020,103 | 78.97M | Jun 29, 2026 |
| Avoro Capital Advisors LLC | 5.59% | 1,444,039 | 56.45M | Jun 29, 2026 |
| Baker Bros. Advisors, LP | 4.98% | 1,286,411 | 50.29M | Jun 29, 2026 |
| Balyasny Asset Management LP | 4.03% | 1,042,198 | 40.74M | Jun 29, 2026 |
| Cormorant Asset Management, LP | 3.98% | 1,028,242 | 40.19M | Jun 29, 2026 |
| RA Capital Management, L.P. | 2.79% | 722,020 | 28.22M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 0.19% | 48,771 | 1.91M | Apr 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.06% | 15,907 | 621.80K | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.04% | 10,115 | 395.39K | Jun 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.02% | 4,560 | 178.25K | Jul 30, 2026 |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 0.01% | 1,360 | 53.16K | Apr 29, 2026 |
| iShares Trust-iShares Micro-Cap ETF | 0.01% | 3,192 | 124.78K | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAMBRIAN BIOPHARMA INC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 31, 2026 | 130,142 |
| HAHN STEPHEN M | Director | Conversion of Exercise of derivative security | Jun 14, 2026 | 44,763 |
| MILLENNIUM MANAGEMENT, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 6, 2026 | 0 |
| PARIKH ANAND KIRAN J.D. | Chief Executive Officer | Conversion of Exercise of derivative security | Jun 21, 2026 | 817,699 |
| PEYER JAMES | Beneficial Owner of more than 10% of a Class of Security | Sale | May 31, 2026 | 130,142 |
| STEPHENSON BRIAN C | Chief Financial Officer | Purchase | Jun 30, 2026 | 0 |
